James P. Shaffer, VP & Chief Commercial Officer at HALOZYME THERAPEUTICS INC (HALO), bought 20,000 shares at $5.22 ($104K) on 2012-11-14, disclosed to the SEC on 2012-11-14.
Open-market purchase of $104k HALO by VP & Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| Filing → |
| EIGR | BUY | 2016-05-23 | $25K | — | Filing → |